Turn recording back on
How does endothelial cell injury start? The role of endothelin in systemic sclerosis.
Abraham D, Distler O.
Arthritis Res Ther. 2007;9 Suppl 2:S2. Review.
PMID: 17767740 [PubMed - indexed for MEDLINE]
Related Articles Free article in PMC
Statins and the vasculopathy of systemic sclerosis: potential therapeutic agents?
Derk CT, Jimenez SA.
Autoimmun Rev. 2006 Jan;5(1):25-32. Epub 2005 Aug 19. Review.
PMID: 16338208 [PubMed - indexed for MEDLINE]
Related Articles
Genetic factors in systemic sclerosis.
Mayes MD, Trojanowska M.
Arthritis Res Ther. 2007;9 Suppl 2:S5. Review.
PMID: 17767743 [PubMed - indexed for MEDLINE]
Therapeutic targets in systemic sclerosis.
Denton CP.
Arthritis Res Ther. 2007;9 Suppl 2:S6. Review.
PMID: 17767744 [PubMed - indexed for MEDLINE]
Potential benefit of statins for vascular disease in systemic sclerosis.
Kuwana M.
Curr Opin Rheumatol. 2006 Nov;18(6):594-600. Review.
PMID: 17053504 [PubMed - indexed for MEDLINE]
Endothelin receptor antagonism--new perspectives in the treatment of systemic sclerosis.
Kowal-Bielecka O, Sierakowski S.
Rocz Akad Med Bialymst. 2005;50 Suppl 1:291-3. Review.
PMID: 16119689 [PubMed - indexed for MEDLINE]
Radical oxygen species production induced by advanced oxidation protein products predicts clinical evolution and response to treatment in systemic sclerosis.
Servettaz A, Guilpain P, Goulvestre C, Chéreau C, Hercend C, Nicco C, Guillevin L, Weill B, Mouthon L, Batteux F.
Ann Rheum Dis. 2007 Sep;66(9):1202-9. Epub 2007 Mar 15.
PMID: 17363403 [PubMed - indexed for MEDLINE]
The vascular perspective of systemic sclerosis: of chickens, mice and men.
Sgonc R.
Int Arch Allergy Immunol. 1999 Nov;120(3):169-76. Review.
PMID: 10592461 [PubMed - indexed for MEDLINE]
Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis.
Koch AE, Distler O.
Arthritis Res Ther. 2007;9 Suppl 2:S3. Review.
PMID: 17767741 [PubMed - indexed for MEDLINE]
Targeting vascular disease in systemic sclerosis.
Kowal-Bielecka O.
Endocr Metab Immune Disord Drug Targets. 2006 Dec;6(4):401-7. Review.
PMID: 17214586 [PubMed - indexed for MEDLINE]
Vasoactive therapies in systemic sclerosis.
Riemekasten G, Sunderkötter C.
Rheumatology (Oxford). 2006 Oct;45 Suppl 3:iii49-51. Review. Erratum in: Rheumatology (Oxford). 2008 Feb;47(2):234-5.
PMID: 16987836 [PubMed - indexed for MEDLINE]
Vascular involvement in systemic sclerosis (SSc).
Kahaleh MB.
Clin Exp Rheumatol. 2004 Jan-Feb;22(3 Suppl 33):S19-23. Review.
PMID: 15344592 [PubMed - indexed for MEDLINE]
Autoimmunity and vascular involvement in systemic sclerosis (SSc).
Kahaleh MB, LeRoy EC.
Autoimmunity. 1999;31(3):195-214. Review.
PMID: 10739336 [PubMed - indexed for MEDLINE]
[Current pathophysiological aspects of systemic sclerosis]
Krieg T, Hunzelmann N.
Z Rheumatol. 2006 Jul;65(4):275-8. Review. German.
PMID: 16807741 [PubMed - indexed for MEDLINE]
Pathogenesis of scleroderma (systemic sclerosis).
LeRoy EC.
J Invest Dermatol. 1982 Jul;79 Suppl 1:87s-89s.
PMID: 7086194 [PubMed - indexed for MEDLINE]
[Systemic sclerosis: pathophysiology of a multifaceted disease]
Servettaz A, Agard C, Tamby MC, Guilpain P, Guillevin L, Mouthon L.
Presse Med. 2006 Dec;35(12 Pt 2):1903-15. Review. French.
PMID: 17159716 [PubMed - indexed for MEDLINE]
The pathology of scleroderma vascular disease.
Fleming JN, Schwartz SM.
Rheum Dis Clin North Am. 2008 Feb;34(1):41-55; vi. Review.
PMID: 18329531 [PubMed - indexed for MEDLINE]
Update on pathophysiology of scleroderma with special reference to immunoinflammatory events.
Chizzolini C.
Ann Med. 2007;39(1):42-53. Review.
PMID: 17364450 [PubMed - indexed for MEDLINE]
Endothelins in health and disease: an overview.
Goldie RG.
Clin Exp Pharmacol Physiol. 1999 Feb;26(2):145-8. Review.
PMID: 10065336 [PubMed - indexed for MEDLINE]
[Genetic factors predisposing to fibrosis in systemic sclerosis]
Granel B, Chevillard C, Dessein A.
Rev Med Interne. 2005 Apr;26(4):294-303. Review. French.
PMID: 15820565 [PubMed - indexed for MEDLINE]